Canada is investing more than $4 million in a largest study of environmental chemicals in pregnant women and their babies. – The Government of Canada announced a $3.9 million investment in Canada’s largest study of environmental chemicals in pregnant women and their babies. To mark National Child Day and the one-year anniversary of the Chemicals Management Plan on December 8, the Honourable Tony Clement, Minister of Health, Canada announced this important step.
Nonprescription drug Zyrtec, cetirizine HCl, is approved for the temporary relief of symptoms due to hay fever or other respiratory allergies. – Different formulations of the nonprescription drug Zyrtec (cetirizine HCl) is approved for the temporary relief of symptoms due to hay fever or other respiratory allergies (sneezing; runny nose; itchy, watery eyes; itchy throat or nose) in adults and children 2 years of age and older.
A protein in humans known as RGS13 suppresses allergic reactions, including the severe, life-threatening allergic reaction known as anaphylaxis. – According to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), a protein in mice known as RGS13 suppresses allergic reactions, including the severe, life-threatening allergic reaction known as anaphylaxis.
Harmful cosmetic eye products may increase the risk of optic nerve damage, macular edema, uveitis leading to decreased vision and blindness. – At the request of the U.S. Food and Drug Administration, U.S. Marshals seized 12,682 applicator tubes of Age Intervention Eyelash, a product that may, in some users, lead to decreased vision. Authorities said the sales value of the seized tubes is approximately $2 million.
Anticancer drug Nexavar raised survival period in inoperable hepatocellular carcinoma patients suffering from this kind of liver cancer. – The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable. Nexavar was originally approved in 2005 for the treatment of patients with advanced renal cell carcinoma, a form of kidney cancer.